Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $197.5, along with a high estimate of $209.00 and a low estimate of $183.00. This current ...

UK engineering firm Smiths Group has begun talks with the US company ICU Medical about merging the two firms' healthcare operations. In a statement, Smiths said it was in "very early discussions ...

ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier ...

Keybanc：维持ICU Medical(ICUI.US)评级，由增持调整至增持评级, 目标价由198.00美元调整至209.00美元。 ICU医疗（ICUI.US）公司简介：ICU Medical 是一家总部位于 ...